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Abstract
Background: Outbreaks of acute Chagas disease associated with oral transmission are easily detected nowadays with
trained health personnel in areas of low endemicity, or in which the vector transmission has been interrupted. Given
the biological and genetic diversity of Trypanosoma cruzi, the high morbidity, mortality, and the observed therapeutic
failure, new characteristics of these outbreaks need to be addressed at different levels, both in Trypanosoma cruzi as in
patient response. The aim of this work was to evaluate the patient’s features involved in six outbreaks of acute Chagas
disease which occurred in Santander, Colombia, and the characteristics of Trypanosoma cruzi clones isolated from these
patients, to establish the potential relationship between the etiologic agent features with host behavior.
Methods: The clinical, pathological and epidemiological aspects of outbreaks were analyzed. In addition, Trypanosoma
cruzi clones were biologically characterized both in vitro and in vivo, and the susceptibility to the classical trypanocidal
drugs nifurtimox and benznidazole was evaluated. Trypanosoma cruzi clones were genotyped by means of mini-exon
intergenic spacer and cytochrome b genes sequencing.
Results: All clones were DTU I, and based on the mini-exon intergenic spacer, belong to two genotypes: G2 related
with sub-urban, and G11 with rural outbreaks. Girón outbreak clones with higher susceptibility to drugs presented G2
genotype and C/T transition in Cyt b. The outbreaks affected mainly young population (±25.9 years), and the mortality
rate was 10 %. The cardiac tissue showed intense inflammatory infiltrate, myocardial necrosis and abundant amastigote
nests. However, although the gastrointestinal tissue was congestive, no inflammation or parasites were observed.
Conclusions: Although all clones belong to DTU I, two intra-DTU genotypes were found with the sequencing of the
mini-exon intergenic spacer, however there is no strict correlation between genetic groups, the cycles of the parasite
or the clinical forms of the disease. Trypanosoma cruzi clones from Girón with higher sensitivity to nifurtimox presented
a particular G2 genotype and C/T transition in Cyt b. When the diagnosis was early, the patients responded well to
antichagasic treatment, which highlights the importance of diagnosis and treatment early to prevent fatal outcomes
associated with these acute episodes.
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Background
Chagas disease (CD) caused by Trypanosoma cruzi affects
about 8 million people in Latin America [1]. In Colombia,
it is estimated that 1.3 million people are infected, and 3.6
million are at risk [2]. The department of Santander has a
seroprevalence rate close to 40 % in most endemic areas
[2]. CD has two clinical phases: acute phase is usually
asymptomatic, and chronic phase in which about 10-30 %
of infected patients develop symptoms [3], and 70 % could
remain asymptomatic, (indeterminate form) [3]. Chronic
Chagasic cardiomyopathy (CCC) is the most common and
severe manifestation, and occurs after 10 – 20 years
following the infection. The digestive forms of CD occur
almost exclusively in Argentina, Brazil, Chile and Bolivia,
although they have also been reported in Mexico, and
Colombia [3–5].
Differences in biological characteristics among T. cruzi
isolates have been demostrated [6, 7], and the correlation
between genotypic and phenotypic aspects of parasite
behaviour was confirmed by Revollo et al. [8] Some of
these biological features of the T. cruzi genotypes are rele-
vant, since they might be associated with pathogenesis or
drug susceptibility [9]. In this regard, efforts to analyze the
relevance of these differences in pathogenesis of CD are ne-
cessary. T. cruzi has a high degree of genetic variability, and
is classified in six phylogenetic groups (discrete typing
units, DTUs), categorized from TcI to TcVI [10]. In
Colombia, most isolates obtained from diverse sources have
been classified as TcI, but in the Santander Department,
TcII have also been found in chronic cases of CD [11–15].
A new subdivision within TcI parasites has been reported
using nuclear and mitochondrial molecular markers as
miniexon and cytochrome b gene sequencing, respectively
[16–18]. Some of these TcI variants seem to be associated
with humans and peridomestic and sylvatic transmission
cycles [18]. However, recent reviews identified that al-
though there are genetic and geographical structures, these
are not strictly associated with cycle and host origins [19].
No vaccines are available so far, and there are only
two registered drugs, the nitrofuran derivative, nifurti-
mox (Lampit, Bayer) and 2-nitroimidazole benznida-
zole (Radanil, Roche), being especially effective in
newborns, and in the acute phase [1]. However, these
drugs have severe limitations of long protocols of treat-
ment and potential harmful side-effects. Also, T. cruzi
strains with natural resistance have been reported [20],
and these drugs have limited efficacy, depending on the
phase of infection, the patient’s age, and the involved
endemic area. [21, 22] This last point could be related to
differences in drug susceptibility among T. cruzi genetic
variants [1, 20].
In addition to chronic CD, acute cases of CD have been
reported early in French Guiana and Brazil since 1941
[23]. Currently, close to 78 % of the acute outbreaks are
related with oral transmission through contaminated food
[23, 24]. Most of them are reported in the Amazonian
region and Southern Brazil, Venezuela, and French Guiana
[24–30]. Although, in most of the acute cases TcI parasites
were found; TcII, TcIII, TcIV and TcV have also been doc-
umented [31–34]. In Colombia, the first acute CD report
was in the Norte de Santander Department, in 1992 [35].
Subsequently, in the period 2002–2005, other cases were
reported from several geographic regions of Colombia,
including Santander Department [36]. In 2006, nine new
acute CD cases were reported [37]. Between 2008 and
2009 outbreaks of probable oral transmission were re-
ported in Santander [33, 38]. The purpose of this study
was to evaluate the clinical and pathological features of
patients involved in six outbreaks from Santander, between
2008 to 2010, and the biological and genetic characteristics
of T. cruzi clones isolated from twelve of these patients.
We report that all clones were DTU I, with intra-DTU
genotypes G2 and G11. These genotypes had differential
distribution in urban and rural areas, and the G2 genotype
was more susceptible to drugs analysed.
Methods
Ethics, consent and permissions
Patients were included in the study after written informed
consent, according to the declaration of Helsinki. For chil-
dren enrolled in the study, written informed consent was
given by parents. The study was approved by the Ethical
Committee of the Universidad Industrial de Santander
(approval number 012/2009). Patients diagnosed with CD
were treated according to the guidelines of the Colombian
Health Ministry.
All animal handling protocols were performed
according to the “Guide for the Care and Use of
Laboratory Animals”, from the National Institute of
Health, USA (National Research Council (US)
Committee for the Update of the Guide for the Care
and Use of Laboratory Animals. Guide for the care
and use of laboratory animals (8th edition), and
approved by the Institutional Ethical Committee at
the Faculty of Medicine, University of Chile (Protocol
CBA# 0448 FMUCH).
Study areas
Six outbreaks of acute CD were reported in five localities
of the Santander Department. Santander is one of the 32
departments of Colombia located in the northeastern part
of the country. The area is 30,537 km2 with a population of
2’086.649 inhabitants, 87 municipalities and Bucaramanga
as its capital. Santander Department is considered the third
most endemic department for CD in Colombia [39]. Ac-
cording to the Santander Health authorities, six municipal-
ities are considered highly endemic, some of which had
improvement of rural housing and vector control program
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[40]. Municipalities where outbreaks occurred are con-
sidered of low endemicity (incidence rates below 3
000 cases per 100 000 inhabitants), except Lebrija and
San Vicente de Chucurí with an incidence rate of 12 to
24000 cases per 100 000 inhabitants, and where there are
no reports of domiciliated vectors. The first outbreak oc-
curred in December 2008 in the town of Lebrija, in 2009
there were two outbreaks, one in a peri-urban area of the
Bucaramanga city (Barrio Bucaramanga), and another in
Piedecuesta. In 2010 three outbreaks occurred, one in the
town of San Vicente de Chucurí, another in the town of
Girón, and the third in a peri-urban area of Bucaramanga
city (Barrio Morrorico) (Fig. 1).
Parasites
Twelve T. cruzi isolates from 30 patients of six outbreaks
of acute CD (2008 to 2010) in Santander Department
from Colombia were used in this study (Table 1). In
addition, the 338clBb (TcI) and Sylvio X10 (TcI) were used
as a chronic isolate and reference strain, respectively
(non-outbreak strains). The parasites were isolated by
hemocultures as previously described [41]. The isolates
were cloned using an isolation method of single colonies
on solid medium [42], resulting in 5–10 clones per isolate,
for each isolate one clone was selected. The selected
clones from the different outbreaks were maintained in
LIT medium and subsequently submitted to the different
analysis. The parasites codes, date and place of collection,
and gender and age of the patients are showed in Table 1.
Genotyping of T. cruzi isolates
Seven independent genetic markers were used to genotype
the T. cruzi clones. Mini-exon intergenic spacer (SL-IR),
24Sα rRNA D7 domain and 18S rRNA, were amplified as
previously described [43, 44]. The mitochondrial gene
Cytochrome Oxidase subunit II (COII) was characterized
by nested PCR followed by Alu I restriction endonuclease.
The RFLP analysis was done in 6.0 % polyacrylamide gel
and revealed by silver staining [45], and the Cytochrome b
(Cyt b) gen was amplified as previously described [46].
Additionally, HSP60 and GPI genes were analysed [47].
DNA from T. cruzi strains, representing major genetic
groups TcI and TcII were used as controls for all PCR
assays. In addition, to determine the degree of genetic
similarity of the parasites with the sequences already
reported in GenBank, mini-exon PCR products were
sequenced from T. cruzi clones in the ABI 3730xl DNA
analyzer (Applied Biosystems, Foster City, CA, USA).
Purification and direct sequencing of DNA amplicons of
Cytb gene were performed by MACROGEN (Seoul, South
Korea).
Fig. 1 Geographical distribution and location of the municipalities in Santander, Colombia where acute Chagas outbreaks occurred. Gray-scaled
map shows the Santander department. The Chagas Disease incidence in each municipality is indicated with one of the four gray scales indicated
in the picture. The geographical distribution of the outbreaks described in this article is specified with the colored circles
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Editing and alignment
SL-IR sequences and Cyt b genes were edited using BioEdit
software v.7.0.9 [48], and aligned with ClustalW algorithm
[49]. For SL-IR the sequence was resolved for 192 positions
taking into account the microsatellite region at the begin-
ning of the sequences and with the putative motif (GT)n
(ATGT)n (AT)n (GT)n and the end with GCGTGT [19],
and for Cytb the sequence was resolved for 516 bp. Refer-
ence genotypes were obtained from the GenBank database:
AM259467 and AM259479.1. The sequences were ana-
lysed with the entire microsatellite region and without this
motif as was described [19].
Biological features of T. cruzi clones in vitro
Differentiation of T. cruzi epimastigotes
T. cruzi epimastigotes (1 × 106parasites/mL) were cultured
in Grace’s Insect Media (Sigma, St. Louis, USA) with 10 %
hiFCS at 28 °C. Both, numbers of epimastigotes and culture
medium-derived trypomastigote (cmDT) were counted
under a microscope using a hemocytometer chamber after
2, 5, 7, 10, 12, 14, 17, 19, and 21 days. Epimastigotes with
flagellum and which were mobile were counted. Deter-
mination of day of maximum cmDT, and the % of cmDT
(E + T) were calculated at each point of time.
Release-kinetic of mammalian cells derived
trypomastigotes (cellDT)
Vero cells in RPMI 1640 (Gibco, Grand Island, USA)
culture medium supplemented with 10 % hiFCS were
allowed to attach to 24-well plates. After 24 h, a final
number of 1 × 105 adherent cells/mL were infected with
5 × 105 cmDT/mL at 37 ° C, 5 % CO2 for 24 h. Free par-
asites were removed by washing twice with culture
medium. After 24 h, released and mobile cellDT were
counted microscopically every day for 15 days using
eosin yellow.
Infectivity to cultured mammalian cells
Vero cells (ATCC: CCL-81), cultured in RPMI medium
(10 % hiFCS at 37 °C, 5 % CO2 and 95 % humidity), were
plated on glass coverslips in 24-well plates and infected
with cellDT at a 10:1 parasite-to-cell ratio for 24 h. Non-
internalized parasites were removed by washing with
culture medium. Infected cultures were incubated for
24, 48 and 72 h. The cells were fixed with 70 % metha-
nol and stained with Giemsa and the percentage of in-
fected cells and the numbers of amastigotes per cell
were calculated [25, 26].
Drug susceptibility test
For amastigote drug susceptibility test, Vero cells were
infected with cellDT as described above. Infected cells
were treated with benznidazole or nifurtimox ranging
from 0.3 to 300 μM for 120 h. The treatment schedule in-
cluded a second dose after 72 h. Control untreated cells
were maintained with culture medium without drug. After
120 h, the cultures were fixed and stained with Giemsa.
The percentage of infected cells was evaluated by counting
300 Vero cells per coverslip for each condition by light
microscopy. Drug activity was determined by the percent-
age of infected cells in treated and untreated cultures. The
percent of infected cells before the start of the drug treat-
ment was determined in all strains.
In vivo behavior of T. cruzi clones
Mice infection
BALB/c mice (n = 6) of 20–25 g were inoculated orally
with 106 cmDT of each T. cruzi clones studied from the
mortal acute cases (JCR, and JChV), and control clones
for comparative purposes 338clBb and Sylvio X10). Para-
sitemia was registered to assure infection after the 4th
day of inoculation. End point for cardiac studies was
established at the 25th day post infection.
Table 1 Trypanosoma cruzi isolates from acute Chagas disease in Santander, Colombia
ID isolate Outbreak Year Gender Age (years)
MHOM/CO/08/AMa Lebrija (L) 2008 M 23
MHOM/CO/08/JCRa Lebrija(L) 2008 M 21
MHOM/CO/08/EH Lebrija (L) 2008 M 22
MHOM/CO/09/JCHVa Barrio Bucaramanga (BB) 2009 F 3
MHOM/CO/09/PEGAL Piedecuesta (P) 2009 M 6
MHOM/CO/10/SMAY San Vicente (SV) 2010 F 24
MHOM/CO/10/GUICA San Vicente (SV) 2010 F 53
MHOM/CO/10/SATHE Girón (G) 2010 F 8
MHOM/CO/10/DATHE Girón (G) 2010 F 3
MHOM/CO/10/OSGO Girón (G) 2010 M 19
MHOM/CO/10/JLM Girón (G) 2010 M 19
MHOM/CO/10/HEMA Morrorico Bucaramanga (MB) 2010 M 43
aFatal cases
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Heart extraction and histopathological studies from
infected mice
Surviving mice were euthanized at day 25 p.i. and their
hearts were extracted. Hearts were longitudinally sec-
tioned to further analysis by histopathology.
qPCR of heart tissue from infected mice
Heart samples extracted from euthanized animals were
homogenized, and the total genomic DNA was isolated
using a Wizard® Genomic DNA Purification Kit (Promega,
Madison, USA) following the manufacturer’s instructions.
A Real Time PCR TaqMan assay was used to quantify
parasite DNA with method previously described [50]. The
data are expressed as the ratio of T. cruzi DNA to murine
DNA.
Statistical analysis
The in vitro growth kinetics, metacyclogenesis, cell in-
fectivity, and drug activities experiments were performed
in triplicate, with at least two independent experiments.
For all experiments, analysis of variance with Bonferroni
post-test and T test were made, with a confidence level
of 95 %, using the Graphpad Prism software version 5.0.
Values of p <0.05 were considered significant. The drug
activities of benznidazole and nifurtimox were expressed
as the drug concentration able to decrease in a 50 %
(IC50) the number of infected cells. The IC50 values were
determined by four-parameter dose response curve fit-
ting, using the Xlfit4TM program (ID Business Solution,
Guildford, UK).
Results
Epidemiological, clinical and pathological findings
The highest percentage of cases came from the town of
Lebrija (33.3 %), 23.3 % from Bucaramanga, 16.6 % from
Piedecuesta and Girón and 10 % from San Vicente de
Chucurí. Three outbreaks were from rural areas and
three were peri-urban areas. One important epidemio-
logical feature in five of the outbreaks was the presence
of marsupial and insects in the peridomiciliary and ab-
sence of domiciliated triatomines.
The average age of the patients was 25.9 years and 54 %
were male and 46 % were female. The most common
symptoms were fever and malaise (100 %), abdominal pain
(83.3 %) and tachycardia (75 %). Heart failure was present
in 66.6 % and pericardial effusion in 41.6 % of cases
(Table 2). The mortality rate was 10 % (3/30) and one
patient required a heart transplant to save her.
Lebrija outbreak
This outbreak involved 10 individuals. The first patient
diagnosed, three family members, two colleagues and
four workers of the parents’farm. All patients shared
food in this farm, four months before diagnosis. The
diagnosis of acute CD was performed by autopsy of the
first patient and the other patients were diagnosed by
laboratory tests, (parasitological and/or serological tests).
All patients were treated with nifurtimox, nevertheless,
one of the co-workers of the first patient also died as a
consequence of heart failure. The parent’s house was
built with wall of brick with a roof made of tile and cane,
and the floor is made of cement. The kitchen zone was
located in the back part of the house, it was observed
that there were no access to animals and there were no
windows. Three T. cruzi isolates were obtained from
these patients.
In summary, in this outbreak two fatal cases occurred.
The case 1 was diagnosed post-mortem, and whose find-
ings were soft tissue edema, bilateral hydrothorax, ascites,
pulmonary edema and cardiomegaly with dilatation of all
cavities. Histological examination of the heart showed
dense inflammatory infiltrate with diffuse involvement of
the myocardium, abundant cysts occupying most of the
myocardial fibers, T. cruzi amastigote occurrence, and
extensive areas of myocardial necrosis (Fig. 2a, b). At the
level of the esophagus and stomach congestion was
observed marked with lymphocytic infiltrate in the absence
of parasites.
The second case was a patient diagnosed by serological
tests; this patient was treated with nifurtimox, with satis-
factory evolution. A week following discharge from the
hospital, the patient was readmitted with dyspnea, orthop-
nea, cough, hemoptysis but no fever or pain. Clinical evalu-
ation revealed evident arrhythmic heart sounds, decreased
breath sounds, and hepatomegaly. The electrocardiogram
revealed atrial fibrillation with high ventricular response,
and chest radiograph evidenced right pleural effusion. He
Table 2 Signs and symptoms of patients with acute Chagas
disease from Santander, Colombia
Signs and symptoms N (%)
Fever 12 (100)
Malaise 12 (100)
Abdominal pain 10 (83.3)
Tachycardia 9 (75)
Facial edema 8 (66.6)
Headache 8 (66.6)
Heart failure 8 (66.6)
Nausea 7 (58.3)
Breathing difficulty 6 (50)
Chest pain 6 (50)
Vomits 5 (41.6)
Legs edema 5 (41.6)
Pericardial effusion 5 (41.6)
Cough 4 (33.3)
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was moved to the intensive care unit with congestive
heart failure diagnosis, and there, the patient had pro-
gressive deterioration of cardiocirculatory function
and developed cardiogenic shock refractory to the ad-
ministration of intravenous fluids and inotropic drugs,
and he died. The autopsy showed predominantly mono-
nuclear inflammatory infiltrate of lymphocytes in the epi-
cardium and neural ganglia, extending diffusely throughout
the myocardium. Numerous changes were also observed in
the myocardial fibers with necrosis and scarce amastigote
nests (Fig. 2c). Esophagus, small intestine and colon
showed marked congestion without inflammatory disorder,
or parasites.
Bucaramanga outbreak
The Bucaramanga outbreak occurred in a peri-urban
area of Bucaramanga city in February 2009 and involved
five cases of one family: a one year old girl who died, her
mother, her sister, her aunt, and her uncle. The diagnosis
of acute CD was performed on autopsy of the index case
and the other patients were diagnosed by laboratory
tests, (parasitological and/or serological tests). The cases
had symptoms about 15 days before the girl death. All
patients were treated with nifurtimox. The house is lo-
cated in an area surrounded by a wooded area with the
presence of wild animals: rats, marsupials and monkeys.




Fig. 2 Histopathology analysis of hearts from acute Chagas cases occurred in Santander, Colombia. Figures a, and b. Heart sections of the patient 1
from Lebrija outbreak. c. Heart section of the patient 2 from Lebrija outbreak. d. Heart section of the patient from San Vicente outbreak. e. Overview of
the heart of the patient from Bucaramanga (BB) outbreak. f. Heart section of the same patient showed in panel e. (Bucaramanga outbreak). Amastigote
nests are indicated by black arrows
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reported having seen them in the house, in bedroom walls,
ceilings and flying out of the house (17 %) [38]. One T.
cruzi isolate was obtained. The girl was diagnosed by aut-
opsy whose findings were: generalized edema, bilateral
pleural effusions and pericardial ascites, cardiomegaly
(Fig. 2e), linfoplasmohistiocitaria global severe myocarditis
by T. cruzi and amastigote nests (Fig. 2f). Pulmonary
edema, hepatosplenomegaly and generalized mesenteric
lymphadenitis were also observed.
Piedecuesta outbreak
In April of 2009 in a rural area of the Piedecuesta local-
ity occurred the third outbreak which involved five cases
of one family: one boy of six years old, the mother, the
grandmother, a sister and one uncle. The diagnosis was
made by clinical symptoms and confirmed by parasito-
logical (boy) and serological tests (family). The house is
located in an area surrounded by a wooded area. The
kitchen was located at the back of the house and was
easily accessible from the outside. Near the house was a
deposit which generated dirt and proliferation of insect
vectors and different animals, however, at home and
nearby no triatomines were found. All patients were
treated with nifurtimox and they recovered. One T. cruzi
isolate was obtained.
San Vicente de chucurí outbreak
In a rural area of the San Vicente de Chucurí locality in
February 2010 occurred an outbreak involving three
cases: one woman of twenty four years old whose diag-
nosis was made by parasitological test, and two other
cases: the woman’s mother and a colleague who were
identified by serological test. The house was located in
the vicinity of the town, built with walls, roofs and floors
with solid materials and was surrounded by grasslands,
palm trees and a wooded area where insect vectors and
marsupials were found. The patients were treated with
benznidazole. Two T. cruzi isolates were obtained.
The young woman had a positive hemoculture, and
clinically presented chest pain, tachycardia, pericardial
effusion, evolving to heart failure. Therefore, the patient
was subjected to heart transplantation to save her. In the
pathological analysis, the infected heart was normal size
and shape, with 355 g of weight. It presented little
lymphocytic infiltration in the epicardium and the myo-
cardium presented severe necro-inflammatory lesions
represented by a dense infiltrate of lymphocytes, plasma
cells and histiocytes and multiple areas of necrosis with
multiple nests occupying almost the entire cytoplasm of
some myocardial fibers, in which punctate structures
were found inside with diameter between 1–2 microns,
which corresponded to T. cruzi amastigotes. The coron-
ary arteries had normal characteristics and no plaques
were identified (Fig. 2d).
Girón outbreak
In May of 2010 in a peri-urban area of the Girón locality
there was an outbreak involving five cases in one family:
one man of 19 years old who had symptoms 15 days
after the diagnosis was made by parasitological and sero-
logical test. The other cases were: two sisters, a young
man, and a mother. All patients shared a meal and all
were treated with benznidazole. The house was made of
brick and cement floor, but near to the house were palm
trees with the presence of triatomines. Four T. cruzi iso-
lates were obtained.
Morrorico outbreak (Bucaramanga)
In the Morrorico district, a peri-urban area of Bucaramanga
city (BM), in June of 2010 there was an outbreak with two
cases: one man (index case) and his wife. The diagnosis of
the index case was made by parasitological and serological
test and the main symptoms were fever, headache, malaise,
facial edema, tachycardia and heart failure. His wife had
fever and malaise. The kitchen of the house was open to
the yard that is very close to fruit trees and a wooded area.
From the survey it was known that the patient hunted ani-
mals like armadillos and opossums for food. The patients
were treated with benznidazole. One T. cruzi isolate was
obtained.
Genotyping of T. cruzi isolates
Genetic characterization with seven different markers
allowed us to identify that all the T. cruzi isolates of acute
cases belong to DTU I (Additional file 1: Figure S1).
Sequencing and alignments of SL-IR showed that T. cruzi
clones were grouped into two distinct genotypes: G2
(50 %) with the putative motif in microsatellite (GT)8,
(ATGT)2, (AT)1 and (GT)0
19 or Tc Ib previously de-
scribed [17] for clones of Girón, Barrio Bucaramanga and
Morrorico; and G11 (50 %) with the putative motif in
microsatellite (GT)6, (ATGT)1, (AT)1 and (GT)0 or Tc Id
for clones from Lebrija, San Vicente, and Piedecuesta
(Fig. 3a). The analysis of 192 nucleotides without micro-
satellite region showed 11 variable sites and 181 conserved
sites. Although, the alignment of the sequences of Cyt b
gene showed similarity of all clones with genotype C pre-
viously described [51, 52], three clones of Girón, Barrio
Bucaramanga, Piedecuesta and one of San Vicente exhib-
ited a C/T transition at position 237 (50 %) unreported
previously (Fig. 3b).
Biological features of T. cruzi clones in vitro
Differentiation of T. cruzi epimastigotes
Kinetics of epimastigote growth between outbreak isolated
parasites and non-outbreak (338clBb and Silvio X10)
strains are showed in Fig. 4a, b and c. Sylvio X10 strain
grows faster than the parasites isolated from Lebrija pa-
tients (EH, JCR, and AM, Fig. 4a) and also from Morrorico,
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Fig. 3 Sequence alignment of the SL-IR microsatellite region, and TcI sub-classification of T. cruzi clones obtained of patients with acute Chagas
disease in Santander, Colombia. a. Alignment of the SL-IR microsatellite region and TcI sub classification. T. cruziisolates and reference strains b.
Alignment of the Cyt b
Fig. 4 Differentiation of T. cruzi epimastigotes. Epimastigotes were cultured in Grace’s medium and the number of epimastigotes and culture
medium-derived trypomastigote (cmDT) were evaluated. Figures a, b, and c. Epimastigote numbers after 2, 5, 7, 10 and 12 days of assay. d. Day
of maximum numbers of cmDT. e. Maximum percentage of cmDT in total parasites (epimastigotes plus cmDT). Each experiment was evaluated in
triplicate and repeated two times
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Barrio Bucaramanga and San Vicente patients (Fig. 4b).
Parasites isolated from Girón patients (Fig. 4c), showed
different patterns of growth: OSGO and JLM grow faster
than the others showing the maximum parasite numbers
at 7 days, SATHE is the slowest one, and DATHE showed
similar pattern of growth than Sylvio X10. The non-
outbreak isolates used in this study showed a maximal
number of epimastigotes (74–103 × 106 parasites/mL) at
10 days (Fig. 4).
For metacyclogenesis in axenic cultures, cmDT reached
a maximum between 10 and 15 days, without significant
difference between all clones (Fig. 4d). The numbers of
cmDT in acute clones compared with reference strains
were different (p < 0.05). Transformation values below 1 %
on outbreak clones compared with 4.5 and 2 % on
338clBb and Sylvio X-10 clones respectively were
observed. The only exception among the acute clones was
the Piedecuesta clone that reached a 3 % of cmDT trans-
formation (Fig. 4e).
Parasites behavior in mammalian cell culture
All T. cruzi clones were able to infect Vero cells and
transform to amastigotes, showing an increased number
of intracellular parasites up to 72 h (data not shown). A
slight increase of the per cent of infected cells in all
outbreak clones after infection was registered with values
in the range of 30–48 % at 24 h, 33–70 % at 48 h and 43–
74 % at 72 h. A statistically significant (p > 0.05) higher
degree of cell infectivity was observed in the reference
Sylvio X10 strain with values of 92.3 % at 24 h, 93.3 % at
48 h and 96.6 % at 72 h. All the tested clones produced
cellDT from Vero cells as is showed in Fig. 5a, b and c.
JLM and SATHE (both Giron clones) and EH (Lebrija
clone) reached the maximum number of cellDT earlier
than Sylvio X10 clone and JCHV (Barrio Bucaramanga
clone) produced a greater number of cellDT than Sylvio
X10 clone.
Drug susceptibility
We also studied the susceptibility of each clone to nifurti-
mox and benznidazole. At IC50 level, the ranges of suscep-
tibilities were from 2.15 ± 0.17 to 38.28 ± 1.70 μM to
nifurtimox, and 5.30 ± 0.46 to 32.50 ± 3.72 μM to benzni-
dazole. Most of the clones were more susceptible to nifur-
timox than benznidazole, p < 0.05 (Fig. 5d and e). Overall,
the most sensitive clones to nifurtimox were those belong-
ing to the Girón outbreak: SATHE, DATHE, OSGO and
JLM and Morrorico clone (HEMA), these clones showed
Fig. 5 Release of cell derived tripomastigotes (cellDT) and drug susceptibilities of acute outbreaks-parasites. Figures a, b and c. Epimastigotes
were allowed to infect VERO cells and released cellDT were counted each day. The figures showed the numbers of cellDT released by each clone.
Figures d and e. Vero cells were infected with cellDT and treated with increased concentrations of benznidazole (BNZ, figure d) and nifurtimox
(NFZ, figure e) for 5 days. Each drug concentration was evaluated in triplicate and the experiment was repeated two times. The percent of infected
cells before the experiment was 60–90 %
Díaz et al. Parasites & Vectors  (2015) 8:608 Page 9 of 14
a similar susceptibility pattern as the Sylvio X10 reference
clone (Fig. 5d).
In vivo behavior of clones
To explore the possibility of an oral infection in our previ-
ous cases, we studied the infectivity by oral route of two
clones from lethal cases (JChV and JCR clones). Also, we
used the 338clBb clone, obtained from a chronic case, as a
control. 106cmDT from the JChV, JCR and 338clBb clones
were inoculated by oral route in BALB/c mice and the
outcome of the infection was compared with the Sylvio
X10 clone, inoculated by the same route. All clones inocu-
lated by the oral route successfully infected BALB/c mice,
which was corroborated by parasitemia analysis (data not
shown). Only the JChV clone showed mortality at day 25
post infection (1 of 4 mice). The cardiac outcome of the
infection was studied by histology (Table 3) and parasite
load in cardiac tissue by qPCR (Fig. 6). As Table 3 shows,
JChV-infected mice presented more inflammatory infil-
trate and amastigote nests. This correlates with the qPCR
quantification, where mice infected with JChV clone had
104 more parasites than mice infected with Sylvio X 10
clone, used as reference. In addition, 66 % (2 of 3) mice
infected with the JChV clone showed one or more amasti-
gote nests in the histopathology. JCR and 338clBb clones
induced low inflammation in cardiac tissue, similar to
Sylvio X10 infection. JCR-infected mice did not show
amastigote nests, whereas 50 % (2 of 4) of mice infected
with 338clBb clone did, but to a lesser extent than the
JChV infection (Fig. 6).
Discussion
In Colombia, the departments with the highest infest-
ation prevalence are located in the northeastern region
[39], and since 1996 with the start of the vector control
programs the number of domiciliated vectors decreased
in highly endemic regions [53]. However, risk for human
infection continue due to the natural infection rates in
most sylvatic triatomine species that sporadically invade
human dwellings, and the presence of houses close to
palm trees occupied by triatomines and marsupials, both
frequently infected [54, 55]. The mammalian reservoirs
infected as well as the massive displacement of human
populations have increased the risk of transmission of T.
cruzi even in areas of low endemicity. In Colombia, simi-
lar to what happened in northeast Brazil and Venezuela,
these factors would be related to the increased outbreak
reports of acute CD probably associated with oral trans-
mission by food contamination [29, 32].
Santander has been the department with the highest
number of outbreaks described (6/9). Although it is the
third department of Colombia with triatomine house
infestation [39], most of the outbreaks occurred in towns
of low endemicity in which there are no reports of domi-
ciliated triatomines. This finding and the fact that all cases
occurred in rural or suburban areas with conditions favor-
ing entry of sylvatic vectors or wild reservoirs to housing,
support the hypothesis of oral transmission [29]. There is
also the possibility of transmission by food contamination
with urine or anal secretions of infected marsupials
[55, 56]. In five of the outbreaks of this study, the presence
of marsupials in the peridomestic area was reported.
These outbreaks involved a small number of infected
individuals, primarily associated with family outbreaks or
individuals who attended and fed in the same house. The
mortality was high especially during the first outbreak,
Table 3 Histopathology of tissues from mice with acute Chagas







MHOM/CO/09/JCHV 1 Moderate (0-1/c 40X)
2 Moderate (2-3/c 40X)
3 Abundant None




MHOM/CO/01/338clBb 1 Scarce None
2 Scarce None
3 Scarce (0-1/c 40X)
4 Scarce (0-1/c 40X)




aNumbering mice correlate with those shown in Fig. 6 (qPCR)
bNo. of amastigote nests found on examination 40X
Fig. 6 Parasite load quantitation in heart from mice infected orally with
T. cruzi clones. BALB/c mice were infected with four different clones and
the parasite load was measured by qPCR at day 20 post-infection. Each
bar represents one mouse measured by triplicate
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probably due to late diagnosis by nonspecific clinical
symptoms and because these cases were unusual in the
region. The clinical suspicion is directed to other endemic
diseases particularly dengue with similar early clinical
symptoms. The frequency and the symptoms observed
were similar to those in the majority of acute CD out-
breaks reported [25, 27, 29, 32, 57, 58]. The histopatho-
logical findings of four hearts from patients, showed an
intense inflammatory infiltrate in the interstitium, and the
presence of amastigote nests in myocardial fibers. How-
ever, this inflammatory injury not only compromised the
myocardial fibers but also damaged the ganglion cells and
nerve fibers of the heart. These results contrast with
chronic forms in which there is prevalence of fibrosis
represented by fibroblasts and fibrocytes accompanied by
matrix collagen deposit which replaced the myocardial
fibers [15]. In digestive tract tissue of three autopsies per-
formed, we observed marked congestion without tissue
damage or the presence of parasites. The difference ob-
served between the two patients of the Lebrija outbreak
could be related to the fact that case 1 was not treated,
and this correlates with the presence of an intense inflam-
matory infiltrate and numerous amastigote nests. Con-
versely, the second case that received treatment, also
showed abundant inflammatory infiltrate, however, they
presented nerve fiber damage and fewer groups of amasti-
gotes. Damage to the nerve fiber generated conduction
disturbances, which finally led to heart failure.
The isolates obtained in the six outbreaks belong to TcI
that is the DTU most abundant and widely distributed in
America, both in the domestic and sylvatic environments.
In Colombia this DTU is dominant and it is associated
with CCC [11, 12, 14]. Based on intergenic sequences of
the mini-exon gene the clones were grouped into the G2
and G11 genotypes, which are also the most common in
Colombia associated, not only with humans but also with
vectors and reservoirs [18, 19]. All clones in each outbreak
were genetically identical; however, it is important to clarify
that we only analysed one clone of each isolate; therefore
we could not confirm the presence of multiclonal infec-
tions as has been described in Colombia and Venezuela
[33, 59]. Herrera et al, reanalysing the variability of the
miniexon microsatellite region of molecular clones from
11 Latin American countries concluded, that although this
region showed one interesting TcI variability that allowed
some genetic and geographic structure; this structure was
not associated with cycle and host origins [19], as previ-
ously proposed [14, 17]. However it is noteworthy that in
our study the clones grouped as G2 (TcIb) occurred in
suburbs of the city surrounded by forested areas with the
presence of vectors, and reservoirs of marsupials or other
rodents around houses, and the clones identified as G11
(TcId) occurred in rural dwellings suggesting both a syl-
vatic transmission. These results and recent reports from
Venezuela [59], and Colombia [33] of the presence of G2,
G7 and G11 genotypes and multiclonal infections in acute
CD patients support the notion that even though there is a
grouping of genotypes, there is not strict correlation be-
tween genetic groups, and the cycles of the parasite or the
clinical forms of the disease.
Although the majority of clones had similar biological
features related with growth, metacyclogenesis and infect-
ivity of mammalian cells, some differences were observed
in Girón outbreak clones which reached maximum growth
peaks and numbers of cellDT earlier than reference clone.
These clones presented a particular G2 genotype and C/T
transition in Cyt b. In the in vivo model of experimental
infection, we show that oral inoculated T. cruzi were able
to infect, and further reach the heart, inducing different
clinical cardiac outcomes, similar to intraperitoneal infec-
tion (data not shown). JChV was the most infective clone;
indeed, was the only lethal clone in Balb/c mice (one of
four infected mice). This clone produced a greater number
of cellDT than reference clone (Sylvio X10). This finding
might be related to the fact that this isolate came from a
fatal case.
T. cruzi clones obtained from all outbreaks were suscep-
tible to both nitroheretocyclic drug in vitro, but nifurtimox
was more active and showed more heterogeneity in the re-
sponse than benznidazole. All clones from Girón outbreak,
HEMA (Morrorico) and GUICA (San Vicente) showed in-
creased susceptibility to nifurtimox compared with clones
of other outbreaks. On the other hand, OSGO (Girón) also
was the most susceptible to benznidazole. In a previous
study with isolates from humans and vectors of Santander,
similar results were obtained related to increased suscepti-
bility to nifurtimox compared with benznidazole [22]. A
study analysing acute outbreaks in Venezuela also showed
that they were more susceptible to nifurtimox [60]. How-
ever, some studies of clinical follow-up of response to treat-
ment with benznidazole of patients with acute CD of
outbreaks from Venezuela and Brazil reported the presence
of parasites on blood cultures post-therapy indicating treat-
ment failure [34, 61]. In contrast, in our work, the drug
susceptibility in vitro was correlated with the response to
treatment with benznidazole or nifurtimox and subsequent
recovery in all patients that received chemotherapy.
The existence of differences in susceptibility to these
compounds of a large number of T. cruzi isolates from
different host, and geographic areas have been reported
[8, 20], suggesting that TcI epimastigotes are more
resistant to antichagasic drugs than other DTUs [8, 62];
however other surveys did not find differences in drug
susceptibility in human chronic cases infected with TcI
[21, 22]. Although in our study all clones belong to TcI,
we found that Girón clones that displayed higher sensi-
tivity to nifurtimox presented a particular G2 genotype
and C/T transition in Cyt b. Studies with human isolates
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obtained in acute phase of CD in Brazilian Amazonia
did not find differences in susceptibility to the drug
between different DTUs [63]. However, they found sta-
tistically significant differences between TcI isolates from
different regions of the Amazonia, similar results to
those observed by us with the Girón outbreak clones.
Similarly, in Venezuela outbreaks of oral acute CD, the
major failure of the treatment was observed in patients
infected with TcId (G11) showing greater susceptibility
of the genotypes TcIb (G2) [34]. Alike, in Mexican iso-
lates from acute and chronic cases found differences in
susceptibility between different genotypes of TcI [64].
Further studies with these isolates could elucidate
whether there are genotypic differences responsible for
these resistance phenotypes, and thus achieve greater
understanding of drug resistance mechanisms. In this
study, when the diagnosis was appropriate and early, all
treated cases responded well to antichagasic treatment,
which highlights the importance of diagnosis and treat-
ment early to prevent fatal outcomes associated with
these acute episodes.
Conclusions
To summarize, all T. cruzi clones belong to DTU I and
two intra-DTU genotypes were found with the sequencing
of the mini-exon intergenic spacer, however there is no
strict correlation between genetic groups, and the cycles
of the parasite or the clinical forms of the disease. The
cardiac tissue showed intense inflammatory infiltrate,
myocardial necrosis and abundant amastigote nests. How-
ever, although the gastrointestinal tissue was congestive,
no inflammation or parasites were observed. These find-
ings represent a major contribution to studies aiming to
associate the etiologic agent features with host behavior,
and highlight the complexity of identifying characteristics
of the parasite that could be involved in the pathogenesis
of the acute Chagas disease.
Additional file
Additional file 1: Figure S1. Genotyping of T. cruzi isolates. Mini-exon
intergenic spacer, 24Sα rRNA, 18S rRNA, glucose-6 phosphate isomerase
(GPI), heat shock protein 60 (HSP60), and mitochondrial gene Cytochrome
Oxidase subunit II (COII) genes were characterized. (TIF 386 kb)
Competing interests
None of the authors have any competing interests in the manuscript.
Authors’ contributions
MLD was responsible for data collection, carried out the isolation, culturing,
cloning and the molecular characterization of T.cruzi. SL and PE carried out
the generation of resistant clones and the biological experiments in vitro; PE
helped to draft the manuscript. RML and AMB were responsible for animal
handling and carried out the biological experiments in vivo; RLM helped to
draft the manuscript. JCM carried out the pathological studies. AS participated
in the design of the study and helped to draft the manuscript. CIG conceived
of the study, and participated in its design and coordination and drafted the
manuscript. All authors reviewed and approved the final manuscript.
Acknowledgements
We thank all the participants in this study for their essential collaboration.
This study was funded by Contract 734–2009, grant 110249326204 from
the “Departamento Administrativo de Ciencia, Tecnología e Innovación,
COLCIENCIAS”, and “Universidad Industrial de Santander, Bucaramanga,
Colombia”. The funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Author details
1Grupo de Inmunología y Epidemiología Molecular (GIEM), Facultad de
Salud, Universidad Industrial de Santander, Bucaramanga, Colombia. 2Grupo
de Investigación en Enfermedades Tropicales (CINTROP), Departamento de
Ciencias Básicas, Escuela de Medicina, Universidad Industrial de Santander,
Bucaramanga, Colombia. 3Programa de Biología Celular y Molecular, Instituto
de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile,
Santiago, Chile. 4Programa de Farmacología Molecular y Clínica, Instituto de
Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago,
Chile. 5Present address: Laboratorio de Farmacología y Farmacogenética,
Instituto de Investigación en Ciencias Odontológicas (ICOD), Facultad de
Odontología, Universidad de Chile, Santiago, Chile. 6Present address: Instituto
de Farmacología y Morfofisiología, Facultad de Ciencias Veterinarias,
Universidad Austral de Chile, Valdivia, Chile. 7Escuela de Microbiología,
Facultad de Salud, Carrera 32 #29-31, Oficina 419, Universidad Industrial de
Santander, Bucaramanga, Colombia.
Received: 2 June 2015 Accepted: 19 November 2015
References
1. World Health Organization. Research priorities for Chagas disease, human
African trypanosomiasis and leishmaniasis. World Health Organ Tech Rep
Ser. 2012;xii:1–100.
2. Gutierrez R, Angulo VM, Tarazona Z, Britto C, Fernandes O. Comparison of
four serological tests for the diagnosis of Chagas disease in a Colombian
endemic area. Parasitology. 2004;129:439–44.
3. Rassi Jr A, Rassi A, Marin-Neto JA. Chagas disease. Lancet. 2010;375:1388–402.
4. Sanchez-Guillen M del C, Lopez-Colombo A, Ordoñez-Toquero G, Gomez-
Albino I, Ramos-Jimenez J, Torres-Rasgado E, et al. Clinical forms of
Trypanosoma cruzi infected individuals in the chronic phase of Chagas
disease in Puebla, Mexico. Mem Inst Oswaldo Cruz. 2006;101:733–40.
5. Florez O, Esper J, Higuera S, Barraza MF, Cabrera HB, Mantilla JC, et al.
Chagasic megacolon associated with Trypanosoma cruzi I in a Colombian
patient. Parasitol Res. 2010;107:439–42.
6. Sanchez G, Wallace A, Olivares M, Diaz N, Aguilera X, Apt W, et al. Biological
characterization of Trypanosoma cruzi zymodemes: in vitro differentiation of
epimastigotes and infectivity of culture metacyclic trypomastigotes to mice.
Exp Parasitol. 1990;71:125–33.
7. Tibayrenc M. Genetic subdivisions within Trypanosoma cruzi (Discrete
Typing Units) and their relevance for molecular epidemiology and
experimental evolution. Kinetoplastid Biol Dis. 2003;2:12.
8. Revollo S, Oury B, Laurent JP, Barnabe C, Quesney V, Carrière V, et al.
Trypanosoma cruzi: impact of clonal evolution of the parasite on its
biological and medical properties. Exp Parasitol. 1998;89:30–9.
9. Macedo AM, Pena SD. Genetic Variability of Trypanosoma cruzi: Implications
for the pathogenesis of Chagas disease. Parasitol Today. 1998;14:119–24.
10. Zingales B, Andrade SG, Briones MR, Campbell DA, Chiari E, Fernandes O,
et al. A new consensus for Trypanosoma cruzi intraspecific nomenclature:
second revision meeting recommends TcI to TcVI. Mem Inst Oswaldo Cruz.
2009;104:1051–4.
11. Zafra G, Mantilla JC, Valadares HM, Macedo AM, Gonzalez CI. Evidence of
Trypanosoma cruzi II infection in Colombian chagasic patients. Parasitol Res.
2008;103:731–4.
12. Gonzalez CI, Ortiz S, Solari A. Colombian Trypanosoma cruzi major
genotypes circulating in patients: minicircle homologies by cross-
hybridization analysis. Int J Parasitol. 2010;40:1685–92.
13. Mantilla JC, Zafra GA, Macedo AM, Gonzalez CI. Mixed infection of
Trypanosomacruzi I and II in a Colombian cardiomyopathic patient. Hum
Pathol. 2010;41:610–3.
Díaz et al. Parasites & Vectors  (2015) 8:608 Page 12 of 14
14. Ramirez JD, Guhl F, Rendon LM, Rosas F, Marin-Neto JA, Morillo CA. Chagas
cardiomyopathy manifestations and Trypanosoma cruzi genotypes
circulating in chronic Chagasic patients. PLoS Negl Trop Dis. 2010;4, e899.
15. Zafra G, Mantilla JC, Jacome J, Macedo AM, Gonzalez CI. Direct analysis of
genetic variability in Trypanosoma cruzi populations from tissues of
Colombian chagasic patients. Hum Pathol. 2011;42:1159–68.
16. Herrera C, Bargues MD, Fajardo A, Montilla M, Triana O, et al. Identifying
four Trypanosoma cruzi I isolate haplotypes from different geographic
regions in Colombia. Infect Genet Evol. 2007;7:535–9.
17. Falla A, Herrera C, Fajardo A, Montilla M, Triana O, Vallejo GA, et al.
Haplotype identification within Trypanosoma cruzi I in Colombian isolates
from several reservoirs, vectors and humans. Acta Trop. 2009;110:15–21.
18. Ramirez JD, Duque MC, Guhl F. Phylogenetic reconstruction based on
Cytochrome b (Cytb) gene sequences reveals distinct genotypes within
Colombian Trypanosoma cruzi I populations. Acta Trop. 2011;119:61–5.
19. Herrera CP, Barnabe C, Breniere SF. Complex evolutionary pathways of the
intergenic region of the mini-exon gene in Trypanosoma cruzi TcI: a
possible ancient origin in the Gran Chaco and lack of strict genetic
structuration. Infect Genet Evol. 2013;16:27–37.
20. Filardi LS, Brener Z. Susceptibility and natural resistance of Trypanosoma
cruzi strains to drugs used clinically in Chagas disease. Trans R Soc Trop
Med Hyg. 1987;81:755–9.
21. Villarreal D, Barnabe C, Sereno D, Tibayrenc M. Lack of correlation between in
vitro susceptibility to Benznidazole and phylogenetic diversity of Trypanosoma
cruzi, the agent of Chagas disease. Exp Parasitol. 2004;108:24–31.
22. Luna KP, Hernandez IP, Rueda CM, Zorro MM, Croft SL, Escobar P. In vitro
susceptibility of Trypanosoma cruzi strains from Santander, Colombia, to
hexadecylphosphocholine (miltefosine), nifurtimox and benznidazole.
Biomedica. 2009;29:448–55.
23. Raccurt CP. Trypanosoma cruzi in French Guinea: review of accumulated
data since 1940. Med Trop (Mars). 1996;56:79–87.
24. Shaw J, Lainson R, Fraiha H. Epidemiology of the first autochthonous cases of
Chagas’ disease recorded in Belem, Para, Brazil. Rev Saude Publica. 1969;3:153–7.
25. Pinto AY, Valente SA, Valente VC. Emerging acute Chagas disease in
Amazonian Brazil: case reports with serious cardiac involvement. Braz J
Infect Dis. 2004;8:454–60.
26. Perez-Gutierrez E, Agrelo RS, Figueroa R. Technical recommendation on
Chagas’ disease epidemiology and prevention, focussing its transmission as
a disease transmitted by food. Rev Soc Bras Med Trop. 2006;39:512–4.
27. Valente SA, da Costa Valente V, das Neves Pinto AY, de Jesus Barbosa Cesar
M, dos Santos MP, Miranda CO, et al. Analysis of an acute Chagas disease
outbreak in the Brazilian Amazon: human cases, triatomines, reservoir
mammals and parasites. Trans R Soc Trop Med Hyg. 2009;103:291–7.
28. Pinto AY, Valente SA, Valente Vda C, Ferreira Junior AG, Coura JR. Acute
phase of Chagas disease in the Brazilian Amazon region: study of 233 cases
from Para, Amapa and Maranhao observed between 1988 and 2005. Rev
Soc Bras Med Trop. 2008;41:602–14.
29. Alarcon De Noya B, Diaz-Bello Z, Colmenares C, Ruiz-Guevara R, Mauriello
L, Zavala-Jaspe R, et al. Large urban outbreak of orally acquired acute Chagas
disease at a school in Caracas, Venezuela. J Infect Dis. 2010;201:1308–15.
30. Carme B, Aune I, Nguyen G, Aznar C, Beaudet B. Four cases of acute
chagasic myocarditis in French Guiana. Am J Trop Med Hyg. 2001;64:162–3.
31. Andrade SG, Campos RF, Steindel M, Guerreiro ML, Magalhaes JB, Almeida MC,
et al. Biological, biochemical and molecular features of Trypanosoma cruzi
strains isolated from patients infected through oral transmission during a 2005
outbreak in the state of Santa Catarina, Brazil: its correspondence with the new
T. cruzi Taxonomy Consensus (2009). Mem Inst Oswaldo Cruz. 2011;106:948–56.
32. Monteiro WM, Magalhaes LK, de Sa AR, Gomes ML, Toledo MJ, Borges L, et
al. Trypanosoma cruzi IV causing outbreaks of acute Chagas disease and
infections by different haplotypes in the Western Brazilian Amazonia. PLoS
One. 2012;7, e41284.
33. Ramirez JD, Montilla M, Cucunuba ZM, Florez AC, Zambrano P, Guhl F.
Molecular epidemiology of human oral Chagas disease outbreaks in
Colombia. PLoS Negl Trop Dis. 2013;7, e2041.
34. Muñoz-Calderon A, Diaz-Bello Z, Valladares B, Noya O, Lopez MC, Alarcón de
Noya B, et al. Oral transmission of Chagas disease: typing of Trypanosoma cruzi
from five outbreaks occurred in Venezuela shows multiclonal and common
infections in patients, vectors and reservoirs. Infect Genet Evol. 2013;17:113–22.
35. Cáceres DNR, Corredor A, Gualdrón L, Slait E, Dib JC. Investigación de un
brote de síndrome febril con miocarditis aguda en Guamal, Magdalena, 7 a
11 de junio de 1999. Colombia: Ministerio de Salud; 1999. p. 170–8.
36. Nicholls RS, Cucunubá ZM, Knudson A, Florez AC, Montilla M, Puerta CJ, et al.
[Acute Chagas disease in Colombia: a rarely suspected disease. Report of 10 cases
presented during the 2002-2005 period]. Biomedica. 2007;27 Suppl 1:8–17.
37. Nicholls RS, Cucunubá ZM, Flórez C, Montilla M. Enfermedad de Chagas
agudo: Un incremento en el número de casos ocurridos en 2006 Colombia.
Ministerio de Salud. 2007:367-78.
38. Zambrano PCZ, Montilla M, Flórez A, Edgar P, Ramirez AN, Echeverría L, et al.
Brotes de Síndrome Febril Asociado a Miocarditis Aguda Chagásica de Posible
Transmisión Oral en el Departamento de Santander, Colombia, diciembre de
2008 a mayo de 2009. Colombia: Ministerio de Salud; 2010. p. 17–26.
39. Moncayo A. () Chagas disease: current epidemiological trends after the
interruption of vectorial and transfusional transmission in the Southern
Cone countries. Mem Inst Oswaldo Cruz. 2003;98:577–91.
40. Guhl F, Restrepo M, Angulo VM, Antunes CM, Campbell-Lendrum D, Davies
CR. Lessons from a national survey of Chagas disease transmission risk in
Colombia. Trends Parasitol. 2005;21:259–62.
41. Miles MA, Toye PJ, Oswald SC, Godfrey DG. The identification by isoenzyme
patterns of two distinct strain-groups of Trypanosoma cruzi, circulating
independently in a rural area of Brazil. Trans R Soc Trop Med Hyg. 1977;71:217–25.
42. Goldberg SS, Chiari E. Growth and isolation of single colonies of
Trypanosoma cruzi on solid medium. J Parasitol. 1980;66:677–9.
43. Souto RP, Fernandes O, Macedo AM, Campbell DA, Zingales B. DNA markers
define two major phylogenetic lineages of Trypanosoma cruzi. Mol Biochem
Parasitol. 1996;83:141–52.
44. Brisse S, Verhoef J, Tibayrenc M. Characterisation of large and small subunit
rRNA and mini-exon genes further supports the distinction of six
Trypanosoma cruzi lineages. Int J Parasitol. 2001;31:1218–26.
45. de Freitas JM, Augusto-Pinto L, Pimenta JR, Bastos-Rodrigues L, Goncalves
VF, Teixeira SM, et al. Ancestral genomes, sex, and the population structure
of Trypanosoma cruzi. PLoS Pathog. 2006;2, e24.
46. Brisse S, Henriksson J, Barnabe C, Douzery EJ, Berkvens D, Serrano M, et al.
Evidence for genetic exchange and hybridization in Trypanosoma cruzi based
on nucleotide sequences and molecular karyotype. Infect Genet Evol.
2003;2:173–83.
47. Lewis MD, Ma J, Yeo M, Carrasco HJ, Llewellyn MS, Miles MA. Genotyping of
Trypanosoma cruzi: systematic selection of assays allowing rapid and accurate
discrimination of all known lineages. Am J Trop Med Hyg. 2009;81:1041–9.
48. T H. BioEdit: a user-friendly biological sequence alignment editor and
analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser. 1999;41:4.
49. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. The
CLUSTAL_X windows interface: flexible strategies for multiple sequence
alignment aided by quality analysis tools. Nucleic Acids Res. 1997;25:4876–82.
50. Molina-Berrios A, Campos-Estrada C, Lapier M, Duaso J, Kemmerling U,
Galanti N, et al. Benznidazole prevents endothelial damage in an
experimental model of Chagas disease. Acta Trop. 2013;127:6–13.
51. Spotorno OA, Cordova L, Solari A. Differentiation of Trypanosoma cruzi I
subgroups through characterization of cytochrome b gene sequences.
Infect Genet Evol. 2008;8:898–900.
52. Cura CI, Mejia-Jaramillo AM, Duffy T, Burgos JM, Rodriguero M, Cardinal MV,
et al. Trypanosoma cruzi I genotypes in different geographical regions and
transmission cycles based on a microsatellite motif of the intergenic spacer
of spliced-leader genes. Int J Parasitol. 2010;40:1599–607.
53. Campbell-Lendrum DH, Angulo VM, Esteban L, Tarazona Z, Parra GJ,
Restrepo M, et al. House-level risk factors for triatomine infestation in
Colombia. Int J Epidemiol. 2007;36:866–72.
54. Angulo VM, Esteban L, Luna KP. Attalea butyracea palms adjacent to
housing as a source of infestation by Rhodnius prolixus (Hemiptera:
Reduviidae). Biomedica. 2012;32:277–85.
55. Pinto CM, Ocana-Mayorga S, Lascano MS, Grijalva MJ. Infection by
trypanosomes in marsupials and rodents associated with human dwellings
in Ecuador. J Parasitol. 2006;92:1251–5.
56. Bastos CJ, Aras R, Mota G, Reis F, Dias JP, de Jesus RS, et al. Clinical outcomes of
thirteen patients with acute chagas disease acquired through oral transmission
from two urban outbreaks in northeastern Brazil. PLoS Negl Trop Dis. 2010;4, e711.
57. Rios JF, Arboleda M, Montoya AN, Alarcon EP. Probable outbreak of oral
transmission of Chagas disease in Turbo, Antioquia. Biomedica. 2011;31:185–95.
58. Muñoz C, Zulantay I, Apt W, Ortiz S, Schijman AG, Bisio M, et al. Evaluation
of nifurtimox treatment of chronic Chagas disease by means of several
parasitological methods. Antimicrob Agents Chemother. 2013;57:4518–23.
59. Muñoz-Calderón A, Santaniello A, Pereira A, Jannuzzi J, Díaz-Bello Z, Alarcón
de Noya B. Susceptibilidad in vitro a Nifurtimox y Benznidazole de aislados
Díaz et al. Parasites & Vectors  (2015) 8:608 Page 13 of 14
de Trypanosoma cruzi obtenidos de pacientes venezolanos con enfermedad
de Chagas infectados por mecanismos de transmisión oral y vectorial. Rev
Ibero-Latinoam Parasitol. 2012;71(1):14–22.
60. Pinto AY, Valente Vda C, Coura JR, Valente SA, Junqueira AC, Santos LC,
et al. Clinical follow-up of responses to treatment with benznidazol in
Amazon: a cohort study of acute Chagas disease. PLoS One. 2013;8, e64450.
61. Toledo MJ, Bahia MT, Carneiro CM, Martins-Filho OA, Tibayrenc M, Barnabé
C, et al. Chemotherapy with benznidazole and itraconazole for mice
infected with different Trypanosoma cruzi clonal genotypes. Antimicrob
Agents Chemother. 2003;47:223–30.
62. Teston AP, Monteiro WM, Reis D, Bossolani GD, Gomes ML, de Araújo SM,
et al. In vivo susceptibility to benznidazole of Trypanosoma cruzi strains
from the western Brazilian Amazon. Trop Med Int Health. 2013;18:85–95.
63. Martinez I, Nogueda B, Martinez-Hernandez F, Espinoza B. Microsatellite and
mini-exon analysis of Mexican human DTU I Trypanosoma cruzi strains and
their susceptibility to nifurtimox and benznidazole. Vector Borne Zoonotic
Dis. 2013;13:181–7.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Díaz et al. Parasites & Vectors  (2015) 8:608 Page 14 of 14
